Netri
French tech company | Builders Republic
About
Organ-on-chip company that helps pharma and cosmetics labs predict how a drug candidate affects humans before clinical trials — culturing live neurons as bio-sensors inside microfluidic chips (brain-on-chip, skin-on-chip) built with microelectronics techniques, paired with software to read electrical responses at scale.
Key facts
- Status
- Active
- Sectors
- Healthcare & Life Sciences
- Latest stage
- Series A
- Founded
- 2018
- City
- LYON
- Region
- Auvergne-Rhône-Alpes
- Tracked rounds
- 1
- Amount raised
- 5.0 M€ raised since 2020
Funding rounds
- Series A — 2025
Investors
- Cléry
- Polygone
- Trévise